"10.1371_journal.pmed.1001810","plos medicine","2015-04-07T00:00:00Z","Soo-Yon Rhee; Jose Luis Blanco; Michael R Jordan; Jonathan Taylor; Philippe Lemey; Vici Varghese; Raph L Hamers; Silvia Bertagnolio; Tobias F Rinke de Wit; Avelin F Aghokeng; Jan Albert; Radko Avi; Santiago Avila-Rios; Pascal O Bessong; James I Brooks; Charles A B Boucher; Zabrina L Brumme; Michael P Busch; Hermann Bussmann; Marie-Laure Chaix; Bum Sik Chin; Toni T D’Aquin; Cillian F De Gascun; Anne Derache; Diane Descamps; Alaka K Deshpande; Cyrille F Djoko; Susan H Eshleman; Herve Fleury; Pierre Frange; Seiichiro Fujisaki; P Richard Harrigan; Junko Hattori; Africa Holguin; Gillian M Hunt; Hiroshi Ichimura; Pontiano Kaleebu; David Katzenstein; Sasisopin Kiertiburanakul; Jerome H Kim; Sung Soon Kim; Yanpeng Li; Irja Lutsar; Lynn Morris; Nicaise Ndembi; Kee Peng NG; Ramesh S Paranjape; Martine Peeters; Mario Poljak; Matt A Price; Manon L Ragonnet-Cronin; Gustavo Reyes-Terán; Morgane Rolland; Sunee Sirivichayakul; Davey M Smith; Marcelo A Soares; Vincent V Soriano; Deogratius Ssemwanga; Maja Stanojevic; Mariane A Stefani; Wataru Sugiura; Somnuek Sungkanuparph; Amilcar Tanuri; Kok Keng Tee; Hong-Ha M Truong; David A M C van de Vijver; Nicole Vidal; Chunfu Yang; Rongge Yang; Gonzalo Yebra; John P A Ioannidis; Anne-Mieke Vandamme; Robert W Shafer","Department of Medicine, Stanford University, Stanford, California, United States of America; Hospital Clinic Universitari–Institut dInvestigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain; Tufts University School of Medicine, Boston, Massachusetts, United States of America; Department of Statistics, Stanford University, Stanford, California, United States of America; KU Leuven—University of Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Clinical and Epidemiological Virology, Leuven, Belgium; Department of Global Health and Internal Medicine, Academic Medical Center of the University of Amsterdam, and Amsterdam Institute for Global Health and Development, Amsterdam, the Netherlands; World Health Organization, Geneva, Switzerland; Virology Laboratory CREMER-IMPM, Yaoundé, Cameroon; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden; Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden; Department of Microbiology, University of Tartu, Tartu, Estonia; National Institute of Respiratory Diseases, Centre for Research in Infectious Diseases, Mexico City, Mexico; HIV/AIDS & Global Health Research Programme, Department of Microbiology, University of Venda, Thohoyandou, South Africa; National HIV and Retrovirology Laboratories, Public Health Agency of Canada, Ottawa, Ontario, Canada; Department of Viroscience, Erasmus Medical Centre, Erasmus University, Rotterdam, Netherlands; British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada; Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada; Blood Systems Research Institute, San Francisco, California, United States of America; Botswana–Harvard AIDS Institute Partnership, Gaborone, Botswana; Laboratoire de Virologie, Hôpital Saint Louis, Université Paris Diderot, INSERM U941, Paris, France; Center for Infectious Diseases, National Medical Center, Seoul, Republic of Korea; CIRBA-Programme PACCI, Abidjan, Côte dIvoire; UCD National Virus Reference Laboratory, University College Dublin, Dublin, Ireland; Department of Virology, Pitie-Salpetriere Hospital, Paris, France; Laboratoire de Virologie, Assistance Publique–Hôpitaux de Paris Hôpital Bichat-Claude Bernard, INSERM UMR 1137, Université Paris Diderot, Paris, France; Department of Medicine, Grant Medical College and Sir Jamshedjee Jeejeebhoy Group of Hospitals, Mumbai, India; Global Viral Cameroon, Intendance Round About, EMAT/CRESAR, Yaoundé, Cameroon; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America; Laboratoire de Virologie, Centre Hospitalier Universitaire de Bordeaux, CNRS UMR 5234, Université de Bordeaux, Bordeaux, France; Microbiology Department, Hôpital Necker-Enfants Malades, Paris, France; Influenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan; National Hospital Organization Nagoya Medical Center, Nagoya, Japan; Department of Microbiology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain; Centre for HIV and STIs, National Institute for Communicable Diseases, Johannesburg, South Africa; Department of Viral Infection and International Health, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan; MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda; Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America; Division of AIDS, Korea National Institute of Health, Osong, Chungcheongbuk-do, Republic of Korea; State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China; Institute of Human Virology, Abuja, Nigeria; Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; National AIDS Research Institute, Indian Council of Medical Research, Pune, India; Unité Mixte Internationale 233, Institut de Recherche pour le Développement, INSERM U1175, and University of Montpellier, 34394 Montpellier, France; Computational Biology Institute, Montpellier, France; Institute of Microbiology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia; Department of Medical Affairs, International AIDS Vaccine Initiative, New York, New York, United States of America; Department of Epidemiology and Biostatistics, School of Medicine, University of California, San Francisco, California, United States of America; University of Edinburgh, Edinburgh, Scotland, United Kingdom; Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; University of California San Diego, La Jolla, California, United States of America; Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil; Department of Infectious Diseases, Hospital Carlos III, Madrid, Spain; Institute of Microbiology and Immunology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia; Federal University of Goias, Goias, Brazil; Department of Medicine, University of California, San Francisco, California, United States of America; Institut de Recherche pour le Développement, University of Montpellier 1, Montpellier, France; International Laboratory Branch, Division of Global HIV/AIDS, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America; Stanford Prevention Research Center, Department of Medicine, Stanford University, Stanford, California, United States of America; Meta-Research Innovation Center at Stanford, Stanford University, Stanford, California, United States of America; Global Health and Tropical Medicine, Unidade de Microbiologia, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisbon, Portugal","Conceived and designed the experiments: AMV JLB JPAI MRJ RWS SYR. Performed the experiments: JLB RWS SYR VV. Analyzed the data: JT PL RWS SYR. Contributed reagents/materials/analysis tools: AD AFA AH AKD AT BSC CABB CFD CFDG CY DAMCvdV DD DK DMS DS GMH GRT GY HB HF HHMT HI IL JA JH JHK JIB KKT KPN LM MAP MASo MASt MLC MLRC MPe MPo MPB MR MS NN NV PF PK POB PRH RA RLH RSP RY SAR SF SHE SK SSi SSu SSK TFRdW TTD VVS WS YL ZLB. Wrote the first draft of the manuscript: JLB RWS SYR. Wrote the paper: AH AMV CY DAMCvdV HHMT JA JLB JIB JPAI JT MASo MLRC MR MRJ PL PRH RLH RWS SB SYR. Agree with manuscript results and conclusions: AD AFA AH AKD AT AMV BSC CABB CFD CFDG CY DAMCvdV DD DK DMS DS GMH GRT GY HB HF HHMT HI IL JA JLB JH JHK JIB JPAI JT KKT KPN LM MAP MASo MASt MLC MLRC MPe MPo MPB MR MRJ MS NN NV PF PK PL POB PRH RA RLH RSP RWS RY SAR SB SF SHE SK SSi SSu SSK SYR TFRdW TTD VV VVS WS YL ZLB. All authors have read, and agree that they meet, ICMJE criteria for authorship.","JHK and MR are employees of the Walter Reed Army Institute of Research, however, the views expressed herein are those of the authors and do not represent the official views of the Departments of the Army or Defense. DD has received honoraria and travel grants from Viiv Healthcare, Janssen-Cilag, Gilead-Sciences, MSD and BMS for participation to advisory boards and international conferences. SHE collaborates on research studies with investigators from Abbott Laboratories (distributor of the ViroSeq HIV-1 Genotyping System). Abbott Laboratories has provided reagents and performed testing for some collaborative studies. PF has received paid employment for educational presentation (Bristol-Myers Squibb, Janssen-Cilag), travel grants and honoraria for speaking or participation at meetings (Bristol-Myers Squibb, MSD, Gilead, Astellas). WS has received honoraria for speaking from Viiv, MSD, Janssen and Torii. PRH has received grants from, served as an ad hoc advisor to, or spoke at various events sponsored by: Pfizer, Glaxo-Smith Kline, Abbott, Merck, Tobira Therapeutics, Virco and Quest Diagnostics. MAP was supported in part from the United States Agency for International Development (USAID), however, the contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. SB is a staff member of the World Health Organization and the contents are the responsibility of the authors and do not necessarily reflect the views of the World Health Organization. JPAI is a member of the Editorial Board of PLOS Medicine. All other authors have declared that no competing interests exist.","2015","04","Soo-Yon Rhee","SYR",73,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA
